发明名称 4,5-Dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
摘要 This invention is directed to 4,5-dihydro-(1H)-pyrazole(pyrazoline) derivatives as cannabinoid CB<SUB>1 </SUB>receptor modulators, to pharmaceutical compositions containing these compounds, to methods for the preparation of these compounds, methods for preparing novel intermediates useful for their synthesis, and methods for preparing compositions. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in disorders in which CB<SUB>1 </SUB>receptors are involved, or that can be treated via manipulation of those receptors. The compounds have the general formula (I) wherein the symbols have the meanings given in the specification.
申请公布号 US2007142362(A1) 申请公布日期 2007.06.21
申请号 US20060641725 申请日期 2006.12.20
申请人 SOLVAY PHARMACEUTICALS B.V. 发明人 LANGE JOSEPHUS H.;IWEMA BAKKER WOUTER I.;VAN VLIET BERNARD J.;VAN DER NEUT MARTINA A.
分类号 A61K31/55;A61K31/4152;A61K31/4439;A61K31/4709;C07D403/02 主分类号 A61K31/55
代理机构 代理人
主权项
地址